ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 751 filers reported holding ASTRAZENECA PLC in Q1 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $348,216 | +29.8% | 5,142 | +37.2% | 0.04% | +5.9% |
Q2 2023 | $268,244 | +3.8% | 3,748 | +0.6% | 0.03% | -20.9% |
Q1 2023 | $258,483 | -11.7% | 3,724 | -13.8% | 0.04% | -20.4% |
Q4 2022 | $292,828 | +26.2% | 4,319 | +2.2% | 0.05% | -5.3% |
Q3 2022 | $232,000 | -17.4% | 4,226 | -0.5% | 0.06% | -8.1% |
Q2 2022 | $281,000 | -4.1% | 4,249 | -3.8% | 0.06% | +3.3% |
Q1 2022 | $293,000 | -4.6% | 4,419 | -16.2% | 0.06% | -7.7% |
Q4 2021 | $307,000 | +5.1% | 5,272 | +8.3% | 0.06% | -12.2% |
Q3 2021 | $292,000 | -1.4% | 4,866 | -1.5% | 0.07% | -8.6% |
Q2 2021 | $296,000 | +23.3% | 4,938 | +2.3% | 0.08% | -24.3% |
Q1 2021 | $240,000 | -0.4% | 4,828 | 0.0% | 0.11% | -9.3% |
Q4 2020 | $241,000 | -4.0% | 4,828 | +5.3% | 0.12% | -15.7% |
Q3 2020 | $251,000 | -19.0% | 4,587 | -21.7% | 0.14% | -15.2% |
Q2 2020 | $310,000 | +14.0% | 5,855 | -4.0% | 0.16% | -8.8% |
Q1 2020 | $272,000 | -12.0% | 6,097 | -1.6% | 0.18% | -4.2% |
Q4 2019 | $309,000 | – | 6,197 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |